Cholangiocarcinoma Foundation 7th Annual Conference
Cholangiocarcinoma Foundation 7th Annual Conference
批准号:
9911546
负责人:
Stacie Lindsey
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-01 至 2021-02-28
关键词:
AddressAdvocateAffectAnatomyAttentionBasic ScienceBile duct carcinomaCaregiversCholangiocarcinomaCitiesClinicalClinical ResearchClinical TreatmentCollaborationsCommunitiesConsensusDevelopmentDiagnosisDiseaseEarly DiagnosisEducationEpidemiologyEventFosteringFoundationsFutureGastroenterologyGeneticGoalsHealthImmunotherapyIncidenceIndustryInternationalKnowledgeLeadLiverMalignant NeoplasmsMedicalMentorshipMissionOncologyOralOutcomeParticipantPathologicPatient-Focused OutcomesPatientsPrevalencePreventionPrevention strategyPublic HealthQuality of lifeResearchResearch PersonnelResourcesRisk FactorsScienceScientific Advances and AccomplishmentsSodium ChlorideSymptomsTrainingTranslational ResearchUnited States National Institutes of HealthUtahWorkaggressive therapybench to bedsidebile ductcancer diagnosiscareerclinically relevantdesignevidence baseexperiencehigh risk populationimprovedinnovationmeetingsmortalitymultidisciplinarynovel therapeuticsoutcome forecastpatient engagementposterspreventsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
As a rare and lethal disease, cholangiocarcinoma (CCA) lacks attention and resources. There is
a vast unmet need for education across the entire disease spectrum from bench-to-bedside. As
such, the Cholangiocarcinoma Foundation continues to focus its efforts to educate all
stakeholders in the cholangiocarcinoma community-at-large.
Paramount to that effort, the 2020 Annual Conference has been developed with the following
objectives: 1) Increasing the knowledge and understanding of attendees about key issues
central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma; 2) Identifying
gaps and gathering consensus on rapidly changing advances in basic, translational, and clinical
research; 3) Stimulating international, multi-disciplinary, cross-cooperation and sharing of best
practices by developing, strengthening, and supporting collaborations; 4) Fostering dialogue
and inspiring innovation.
A multidisciplinary audience, including representatives of the scientific, medical and academic
communities; policymakers and regulators, industry, advocates, patients and caregivers will
convene to present a diversity of perspectives focused on evidence-based opinion, compare
current developments, and summarize emerging developments in basic, translational and
clinical research defining the field of CCA.
A global community of experts will review symptoms, incidence, and prevalence in high risk
populations (prevention); examine epidemiological and pathological features of the
heterogeneous group of 3 anatomically distinct cancers (diagnosis); and review advances in
oncology research that are likely to be clinically relevant (treatment and cure).
This setting will also provide a forum to attract and nurture early career researchers with
opportunities to develop and expand their education with mentorship from a global community of
renowned experts. Through oral abstracts, poster sessions, speaker presentations, patient
engagement and more, Young Investigators will forge new alliances, stimulate dialogue and
accelerate global CCA research with the common goal of supporting the Foundation's mission
to find a cure and improve the quality of life for those affected by CCA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金